Trial Profile
Multiple-dose trial of EVT 201 in China
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs Dimdazenil (Primary)
- Indications Insomnia
- Focus Adverse reactions
- Sponsors Zhejiang Jingxin Pharmaceutical
- 30 Mar 2015 New trial record
- 24 Mar 2015 This multiple-dose study was initiated in 2014 by JingXin Pharmaceutical, according to an Evotec media release.